Waters Corporation (NYSE:WAT) April 26, 2015

Stock Price
View Comparative Chart →
Full Screen
1D
Chart
Select Tool
  • O:
  • H:
  • V:
  • C:
  • L:
savecancel
(right-click to delete)
--
WAT-US
Implied Price
OVERVALUED
93.56 126.74
A Price as of Close Apr 24 123.54 USD
B CapitalCube Median Implied Price 109.51 USD * CapitalCube Price is over trading range * CapitalCube Price is below trading range
CapitalCube Estimate Range 100.87 - 118.14 USD NA
52 Week Range 93.56 - 126.74 USD
Earnings Momentum Score
 0  100
A Earnings Score (WAT) 50.37
B Earnings Score(Peer Median) 49.67
Latest Filing date December 31, 2014
Fundamental Score
 0  100
A Fundamental Score (WAT) 66
B Fundamental Score(Peer Median) 53
Analysis
Unlock The Complete Analysis →

Fundamental Analysis

Capital Investment Strategy unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Earnings Leverage unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Leverage & Liquidity unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Relative Valuation unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Valuation Drivers unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Drivers of Margin unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Growth Expectations unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Operations Diagnostic unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Sustainability of Returns unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Likely Corporate Actions

Dividend Action unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Equity Action unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

M&A Action unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Dividend Quality

Dividend unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Accounting Red Flags

Accounting Quality unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Management of Reserves unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Material Categories unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate
Price History

Peers

FA Score

DQ Score

close

52 week range

123.54

93.56

126.74

USD

51.65

38.96

51.96

USD

130.02

107.33

139.03

USD

19.47

17.26

24.93

USD

20.24

16.06

20.85

USD

73.49

56.87

77.39

USD

58.97

36.94

62.00

USD

Company Profile

Waters Corp. is an analytical instrument manufacturing company, that primarily designs, manufactures, sells and services, high performance liquid chromatography, ultra performance liquid chromatography and mass spectrometry technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. It operates through two divisions: Waters Division and TA Division. The Waters division designs, manufactures, distributes and services high performance liquid chromatography and ultra performance liquid chromatography instruments, columns and other chemistry consumables that can be integrated and used along with other analytical instruments. TA Instruments division designs, manufactures, distributes and services thermal analysis, rheometry and calorimetry instruments. The company was founded by James Logan Waters in 1958 and is headquartered in Milford, MA.

Closing Stock Price

USD 123.54

As of Date

April 24, 2015

One Year Performance

12.01%

One Month Performance

0.32%

Industry Group

Medical Specialties

52 wk. Range

USD 93.56 - USD 126.74

Market Cap (Millions)

USD 10,213.92

Total Shares Outstanding

83.147
Latest Filing Dates

Annual

December 31, 2014

Semi Annual

N/A

Quarterly

December 31, 2014

Next Release Date

April 28, 2015

Filing Currency

USD

Listed Exchange

NYSE
Peers


Latest Tweets via StockTwits
WAT
Please login to stocktwits
Post your response
share chart (wait for to display dialog to show)
Message must be no longer than 140 characters.
21
share page
New Filings
1d
$WAT : New SEC Filing for WAT: Form 8-K, No. 0001193125-15-145520 http://stks.co/j2Bdb
Apr 24 2:14 PM
Conference Call Transcripts
1d
Waters Corporation just filed its Current report, items 1.01 and 2.03 http://stks.co/i2Bb3 $WAT
Apr 24 2:12 PM
Capital Market Laboratories
2d
$A vs. $PKI vs. $MTD vs. $WAT Compared Across 9 Critical Measures http://stks.co/r1uVM
Apr 24 8:8 AM
Ophir Gottlieb
2d
$TMO vs. $MTD vs. $A vs. $WAT Compared Across 9 Critical Measures http://stks.co/q1uHS
Apr 23 3:21 PM
Capital Market Laboratories
3d
$ILMN vs. $Q vs. $MTD vs. $WAT Compared Across 9 Critical Measures http://stks.co/g2AdN
Apr 23 11:28 AM
Capital Market Laboratories
3d
$A vs. $PKI vs. $Q vs. $WAT Compared Across 9 Critical Measures http://stks.co/t1u7V
Apr 23 12:17 AM
Capital Market Laboratories
3d
$A vs. $WAT vs. $MTD vs. $VWR Compared Across 9 Critical Measures http://stks.co/f2AWJ
Apr 22 2:56 PM
Victor G
5d
$WAT releasing Earnings on 4/28 Before Open (Confirmed). Anybody buying/selling in Earnings? http://stks.co/d24p4
Apr 21 5:46 AM
Capital Market Laboratories
5d
$WAT Assets are Growing. Here's the Chart: http://stks.co/t1tAb
Apr 21 3:38 AM
Ophir Gottlieb
6d
$TMO vs. $Q vs. $WAT vs. $A Compared Across 9 Critical Measures http://stks.co/e24WO
Apr 20 3:55 AM
Capital Market Laboratories
7d
$ILMN vs. $MTD vs. $A vs. $WAT Compared Across 9 Critical Measures http://stks.co/c24J8
Apr 19 11:2 AM
Capital Market Laboratories
8d
$WAT Revenue is Increasing. Here's the Chart: http://stks.co/r1sCk
Apr 17 10:16 PM
Capital Market Laboratories
9d
$ILMN vs. $A vs. $WAT vs. $Q Compared Across 9 Critical Measures http://stks.co/g28as
Apr 17 1:11 PM
Capital Market Laboratories
9d
$A vs. $PKI vs. $VWR vs. $WAT Compared Across 9 Critical Measures http://stks.co/j28rh
Apr 17 9:10 AM
Ophir Gottlieb
9d
$TMO vs. $ILMN vs. $WAT vs. $Q Compared Across 9 Critical Measures http://stks.co/r1rn6
Apr 16 10:20 PM
Eliminating | Mistakes
10d
"@CapitalMarketLabs: $TMO vs. $ILMN vs. $WAT vs. $A Compared Across 9 Critical Measures http://stks.co/t1rcq http://stks.co/r1rSX";
Apr 16 7:51 AM
Capital Market Laboratories
10d
$TMO vs. $ILMN vs. $WAT vs. $A Compared Across 9 Critical Measures http://stks.co/g284E
Apr 16 7:51 AM
1
Ophir Gottlieb
10d
$A vs. $WAT vs. $MTD vs. $Q Compared Across 9 Critical Measures http://stks.co/s1r7j
Apr 15 8:50 PM
Ophir Gottlieb
10d
$TMO vs. $ILMN vs. $WAT vs. $MTD Compared Across 9 Critical Measures http://stks.co/i288O
Apr 15 3:19 PM
DailyStockPlays.com
11d
End Of Day Scan: Parabolic SAR Sell Signals $AZO $IDXX $WAT $PX $TFX $NTES $UNP $MCO $MTN $LFUS
Apr 14 9:52 PM
Ophir Gottlieb
11d
$ILMN vs. $WAT vs. $Q vs. $MTD Compared Across 9 Critical Measures http://stks.co/d22gh
Apr 14 6:28 PM
PressReleases
12d
$WAT : Waters UPLC I-Class/Xevo TQ-S System Approved for In Vitro ...... http://stks.co/q1qk9
Apr 14 12:50 PM
Finances Stock releases
12d
$WAT Waters UPLC I-Class/Xevo TQ-S System Approved for In Vitro Diagnostic Use in China http://stks.co/b22U5
Apr 14 12:36 PM
Capital Market Laboratories
12d
$TMO vs. $A vs. $MTD vs. $WAT Compared Across 9 Critical Measures http://stks.co/b22NZ
Apr 14 2:21 AM
Ophir Gottlieb
12d
$A vs. $Q vs. $VWR vs. $WAT Compared Across 9 Critical Measures http://stks.co/f27Nb
Apr 14 12:9 AM
Ophir Gottlieb
14d
$A vs. $MTD vs. $VWR vs. $WAT Compared Across 9 Critical Measures http://stks.co/h279k
Apr 12 1:14 PM
Victor G
17d
$WAT releasing Earnings on 4/28 Before Open (Confirmed). Anybody buying/selling in Earnings? http://stks.co/f262K
Apr 9 11:57 AM
Capital Market Laboratories
18d
$TMO vs. $Q vs. $WAT vs. $ILMN Compared Across 9 Critical Measures http://stks.co/q1olm
Apr 8 6:8 AM
Ophir Gottlieb
18d
$ILMN vs. $Q vs. $A vs. $WAT Compared Across 9 Critical Measures http://stks.co/i25b4
Apr 7 9:23 PM
DailyStockPlays.com
18d
End Of Day Scan: 52 Week Highs $IDEA.IN $CSGP $UTHR $ASR $BIO $CI $WAT $ITA $GIII
Apr 7 8:5 PM
Please Login to see your stream! No Twits! Your stream is empty No Twits for WAT!

Closing Stock Price

USD 123.54

As of Date

April 24, 2015

One Year Performance

12.01%

One Month Performance

0.32%

Industry Group

Medical Specialties

52 wk. Range

USD 93.56 - USD 126.74

Market Cap (Millions)

USD 10,213.917

Total Shares Outstanding (Millions)

83.15
Latest Filing Dates

Annual

December 31, 2014

Semi Annual

N/A

Quarterly

December 31, 2014

Next Release Date

April 28, 2015

Filing Currency

USD

Listed Exchange

NYSE
Register
to customize peers
Peer analysis →